Transfusion effect still present with quadruple immunosuppression in recipients of renal transplants.
Yang
H C
HC
Department of Surgery, Pennsylvania State University, College of Medicine, Hershey 17033.
Weaver
A S
AS
Gifford
R R
RR
D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D001803:Blood Transfusion; D004359:Drug Therapy, Combination; D006084:Graft Rejection / Q000187:drug effects; D006085:Graft Survival; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods*; D016030:Kidney Transplantation / Q000379:methods*; D016853:Muromonab-CD3; D011241:Prednisone / Q000627:therapeutic use; D013997:Time Factors
D000911:Antibodies, Monoclonal; D000961:Antilymphocyte Serum; D016853:Muromonab-CD3; D011241:Prednisone